...sy-to-use kits for arraying proteins of interest w...mon lab equipment. DiscoverLight Protein Array Kit...ll lysate or antibody in a low-density array forma...ose membranes with a 384-grid template for arrayin...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...Conjugate Stabilizer is an aqueous solution that c...xic stabilizing chemicals in a MES buffer (4-Morph...duct contains a combination of 0.02% methylisothia...ve. StabilZyme AP Conjugate Stabilizer is formula...
Mouse Anti-Myoglobin Monoclonal Antibody, Biotin Conjugated, Clone 4E2 from Meridian Life Science, Inc.
Biology Products:(Date:12/1/2009)... California waste-to-energy firm claims first p...teration, smallest footprint, salable pure gas, by... (PRWEB) December 15, 2009 -- The...ative organic waste-to-energy process will take pl...nuary. , , ,This biowaste process known as VRAD&c...
(Date:11/30/2009)...ovember 30, 2009 An international team of applied... ETH Zrich have demonstrated compact, multibeam, a...le part of the light spectrum (infrared). By contr...well-defined wavelength. The innovative multibeam ...to remote chemical sensing pollution monitoring, o...
(Date:11/30/2009)... Nov. 30 The Michael J....day announced $1.5 million in total awards to six ...ase-modifying therapies for Parkinson,s disease. T... to Drug Discovery for Parkinson,s Disease progra... plc (NYSE: ELN ), a neuroscience-based biotechn...
(Date:11/30/2009)...RDAM, November 30 Biopharmaceutica...irst patients have been enrolled in its,multinatio... study is,designed to show reduction in transplant...an allogeneic stem cell transplantation with a mis...tients eligible for an allogeneic,stem cell transp...
Breaking Biology Technology:First Public Showing of Innovative Waste-to-Energy Process 2Scientists demonstrate multibeam, multi-functional lasers 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2